New study finds people who have high levels of two markers at high risk of adverse heart events

March 17, 2017
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk. Credit: Intermountain Medical Center

New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.

That's the finding of researchers from the Intermountain Medical Center Heart Institute in Salt Lake City, who teamed with LipoScience Laboratories to examine the markers to see if the two proteins, each previously linked to inflammation, are independent or related and whether either or both can identify patients at elevated risk for cardiovascular events.

Findings from the study will be presented at the American College of Cardiologists Scientific Session in Washington, DC, on March 17.

The research grew out of an earlier analysis that paired plasma samples collected as part of the Intermountain Heart Collaborative Study with an assay developed by LipoScience that uses technology to measure, among other things, the particle numbers in low-density lipoprotein (LDL) cholesterol, often called "bad" cholesterol. While scanning the plasma samples with the nuclear , LipoScience had detected the GlycA and determined it to be a novel marker of inflammation.

Early research by the Intermountain Medical Center Heart Institute team showed that GlycA can predict ; inflammation makes it more likely cholesterol plaques will rupture.

GlycA didn't predict coronary artery disease nearly as well, said J. Brent Muhlestein, MD, co-director of cardiology research at Intermountain Medical Center and the study's lead author.

C-reactive protein has already been shown to accurately predict adverse events and coronary artery disease, so the researchers wondered if the two are independent of each other, or if GLycA just offers another way to measure the effects of CRP.

Using the same —part of more than 30,000 DNA samples collected over the course of 25 years at the Intermountain Medical Center Heart Institute— the researchers compared the value of both GlycA and CRP in predicting future heart attacks, strokes, or death.

For the study, nearly 3,000 patients undergoing coronary angiography were followed, two-thirds of them male. Sixty-five percent of them had been diagnosed with , 42 percent with , and 26 percent with diabetes.

"The correlation between GlycA and CRP was only modest," said Dr. Muhlestein. "Some patients had a high level of one and a low level of the other and vice versa. But the two proteins independently predicted future risk, and if you had both, it was the worst scenario completely. It tells us that GlycA is perhaps something important."

How important will be the focus of future research. Dr. Muhlestein said his research team would like to identify exactly what GlycA is, what it does, and the underlying physiology of its connection to inflammation.

The researchers hope to learn if it can be used as a marker of risk that leads to specific treatments, such as use of statins, which are commonly prescribed to lower cholesterol.

Explore further: Elevated levels of inflammation marker offsets benefits of good cholesterol

Related Stories

Elevated levels of inflammation marker offsets benefits of good cholesterol

April 3, 2016
People with high levels of "good" cholesterol, or high-density lipoprotein, are not as safe from heart disease when high levels of a newly identified biomarker of inflammation in the arteries are also found in their bloodstream, ...

Researchers identify new protein markers that may improve understanding of heart disease

March 30, 2014
Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence ...

Study finds testosterone supplementation reduces heart attack risk in men with heart disease

April 3, 2016
A new multi-year study from the Intermountain Medical Center Heart Institute in Salt Lake City shows that testosterone therapy helped elderly men with low testosterone levels and pre-existing coronary artery disease reduce ...

Levels of ceramides in the blood help predict cardiovascular events

March 9, 2017
Measuring concentrations of a class of lipids known as ceramides in the blood may hold the key to helping clinicians identify individuals with suspected coronary heart disease who need treatment or should be followed more ...

A biomarker for premature death

October 22, 2015
A single blood test could reveal whether an otherwise healthy person is unusually likely to die of pneumonia or sepsis within the next 14 years. Based on an analysis of 10,000 individuals, researchers have identified a molecular ...

Waist circumference is stronger predictor of heart disease than BMI

April 3, 2016
A new study from the Intermountain Medical Center Heart Institute in Salt Lake City and John Hopkins Hospital in Baltimore lends more evidence to the idea that it's better to be shaped like a pear—with weight around the ...

Recommended for you

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

Lasers used to detect risk of heart attack and stroke

August 18, 2017
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of ...

How Gata4 helps mend a broken heart

August 15, 2017
During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts ...

Injectable tissue patch could help repair damaged organs

August 14, 2017
A team of U of T Engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.

'Fat but fit' are at increased risk of heart disease

August 14, 2017
Carrying extra weight could raise your risk of heart attack by more than a quarter, even if you are otherwise healthy.

Air pollution linked to cardiovascular disease; air purifiers may lessen impact

August 14, 2017
Exposure to high levels of air pollution increased stress hormone levels and negative metabolic changes in otherwise healthy, young adults in a recent study conducted in China. Air purifiers appeared to lessen the negative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.